Statements (55)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:Oncology
|
| gptkbp:affects |
plasma cells
|
| gptkbp:clinical_trial |
ongoing research
|
| gptkbp:complication |
infections
kidney damage blood clots bone fractures |
| gptkbp:diagnosis |
gptkb:MRI
gptkb:medical_imaging CT scan blood tests urine tests varies by individual imaging tests bone marrow biopsy |
| https://www.w3.org/2000/01/rdf-schema#label |
active multiple myeloma
|
| gptkbp:is_a |
gptkb:Oncology
|
| gptkbp:is_tested_for |
albumin
M-protein beta-2-microglobulin light chains |
| gptkbp:number_of_stages |
stage I
stage II stage III |
| gptkbp:prevalence |
more common in men
more common in African Americans |
| gptkbp:research |
genetic studies
treatment efficacy survival rates clinical outcomes quality of life studies |
| gptkbp:risk_factor |
age
obesity family history exposure to radiation |
| gptkbp:support |
counseling services
nutritional support patient support groups |
| gptkbp:symptoms |
gptkb:anemia
fatigue bone pain hypercalcemia |
| gptkbp:treatment |
gptkb:immunotherapy
palliative care supportive care radiation therapy chemotherapy targeted therapy corticosteroids stem cell transplant bisphosphonates maintenance therapy novel agents |
| gptkbp:bfsParent |
gptkb:smoldering_multiple_myeloma
|
| gptkbp:bfsLayer |
5
|